Abstract:
본 발명은 칼슘이온 채널 조절제로서 유효한 신규 이미다졸릴알킬카르보닐 유도체와 이의 제조방법 및 이 화합물이 갖는 칼슘이온 채널 억제 효과에 의한 질환 치료제로 사용하는 의약적 용도에 관한 것이다. 이미다졸릴알킬카르보닐 유도체, 칼슘이온 채널 조절제, 뉴런, 탈분극화, 급성통증, 만성통증, 신경병증성 통증, 고혈압치료제.
Abstract:
PURPOSE: A novel benzoarylureido compound is provided to prevent the degeneration and damage of brain cells caused by beta-amyloid and to prevent or treat a neurodegenerative disorder. CONSTITUTION: A novel benzoarylureido compound has a structure of chemical formula 1. A composition for preventing or treating a neurodegenerative disorder contains a compound of chemical formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient. The composition is used in the form of a tablet, injection, capsule, or pill. A health food for preventing or treating a neurodegenerative disorder contains a compound of chemical formula 1 or a pharmaceutically acceptable salt as an active ingredient.
Abstract:
본 발명은 형광편광도를 이용한 파네소이드 X 수용체-리간드 복합체의 상호작용 분석방법 및 결합저해물질 검색방법에 관한 것으로서, 구체적으로 형광편광도를 이용한 파네소이드 X 수용체 (FXR)와 형광표지된 리간드간의 상호작용 분석방법 및 형광표지된 리간드와 파네소이드 X 수용체를 포함한 시료에 결합저해 후보물질을 가하고, 형광편광도를 측정하여 파네소이드 X 수용체에 대한 리간드와 결합저해 후보물질의 경쟁적 결합여부를 확인함으로써 파네소이드 X 수용체와 리간드 복합체의 결합 저해물질 검색방법에 관한 것이다. 본 발명의 상호작용 분석방법 및 결합 저해물질 검색방법은 웰 플레이트를 이용한 초고속 검색에 효과적으로 적용될 수 있어서 고지혈증 치료제 개발에 매우 유용하다. 파네소이드 X 수용체, 형광편광도, 리간드
Abstract:
A modified 5-AMP(adenine monophosphate)-activated protein kinase(AMPK), a method for preparing the same protein kinase, and use thereof are provided to confer the water-soluble and crystalline structure which is more easily analyzed in the three-dimensional structure analysis on the protein kinase, so that the modified protein kinase acts as a target protein of obesity treatment. The method for preparing the modified water-soluble and crystalline 5-AMP-activated protein kinase comprises the steps of: (i) preparing water-soluble modified AMPK protein wherein a preserved protein kinase active domain of AMPK alpha subunit having the amino acid sequence of SEQ ID NO:1 is contained, and one polypeptide molecule selected from 1-12 amino acid sequences from the N-terminal region is deleted, one polypeptide molecule selected from 250-280 amino acid sequences from the C-terminal region is deleted, or both the polypeptide molecules are deleted; and (ii) crystallizing the modified AMPK protein by performing a hanging-drop vapour diffusion method using water tank solution containing a precipitating agent selected from ammonium sulfate and MES(Methyl ester sulfonate) at 16-26 deg.C and pH 6.0-6.5.
Abstract translation:提供了修饰的5-AMP(腺嘌呤单磷酸)激活的蛋白激酶(AMPK),制备相同蛋白激酶的方法及其用途,以赋予在三维中更容易分析的水溶性和晶体结构 对蛋白激酶进行结构分析,使修饰的蛋白激酶作为肥胖治疗的靶蛋白。 制备修饰的水溶性和结晶5-AMP活化蛋白激酶的方法包括以下步骤:(i)制备水溶性修饰的AMPK蛋白,其中AMPKα亚基的保守蛋白激酶活性结构域具有氨基酸序列 含有SEQ ID NO:1,并且选自N末端区域的1-12个氨基酸序列中的一个多肽分子缺失,选自C末端区域的250-280个氨基酸序列中的一个多肽分子缺失,或者 多肽分子都被删除; (ii)通过使用含有选自硫酸铵和MES(甲基酯磺酸盐)的沉淀剂的水罐溶液在16-26℃和pH 6.0-6.5下进行悬滴蒸气扩散方法使修饰的AMPK蛋白质结晶。
Abstract:
PURPOSE: Provided are an mmunostrip paper for the simultaneous detection of philopon and cannabis without involving additional reagents. CONSTITUTION: The mmunostrip paper for the simultaneous detection of philopon and cannabis comprises the parts of: (i) a sample membrane(1) coated with protein and sugar; (ii) a glass fiber membrane(2) positioned under the sample membrane(1) and containing a drug antibody-colored minute particle complex; (iii) a polyester supporting nitrocellulose membrane(3) connected vertically to the glass fiber membrane(2), and containing a test resulting line as a drug-protein complex and a test controlling line as a second antibodies of the drugs in different sites; (iv) a reaction solution absorbing membrane(4) connected vertically to the polyester supporting nitrocellulose membrane(3); and supporting bars positioned under each membrane, wherein the sugar is dextran; the protein is bovine serum albumin; the colored minute particle is colloidal; and the supporting bar is made of polyester resin.